To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides
in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.
Patients with the following conditions are excluded:
- Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal
meningitis) or other conditions (brain abscess) which would make treatment results
difficult to interpret due to concurrent infection, disease, or therapy.
Patients with other opportunistic infections or brain diseases are excluded.
Patients with AIDS and cerebral toxoplasmosis.